Stay updated on Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:49:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    An NIH-wide notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the unavailable study record, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:57:20.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:53:55.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The NCT02799901 study page now shows a 403 Forbidden error instead of the study details. The content and navigation are replaced by a generic access-denied screen.
    Difference
    18%
    Check dated 2026-09-22T22:43:43.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects a deployment/version update rather than a modification to the study information presented.
    Difference
    0.1%
    Check dated 2026-09-15T20:58:29.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page no longer lists the MeSH term 'Melanoma' and the 'related topics' section including 'MedlinePlus Genetics', reducing the amount of contextual topic information shown for the study.
    Difference
    0.2%
    Check dated 2026-09-08T20:02:32.000Z thumbnail image

Stay in the know with updates to Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.